CLINICAL TRIALS PROFILE FOR ABILIFY MYCITE KIT
✉ Email this page to a colleague
All Clinical Trials for abilify mycite kit
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03643159 ↗ | A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 4 | 2018-06-28 | The primary objective of this pragmatic clinical trial (Main Study) was to assess the difference between all-cause hospitalizations in participants using Abilify MyCite versus virtual matched controls. In addition, secondary and exploratory objectives were to assess medication adherence, healthcare utilization and costs, and patient-reported outcomes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for abilify mycite kit
Condition Name
Clinical Trial Locations for abilify mycite kit
Trials by Country
Clinical Trial Progress for abilify mycite kit
Clinical Trial Phase
Clinical Trial Sponsors for abilify mycite kit
Sponsor Name